ENT handheld instruments market seen reaching $13.08 billion by 2030

The ENT handheld instruments market is projected to grow from $8.59 billion in 2025 to $13.08 billion by 2030, driven by hearing-loss cases, outpatient ENT procedures and demand for portable diagnostic tools. North America led the market in 2025, while new product design and infection-control trends are shaping the next phase of growth.

Why it matters: - The ENT handheld instruments market supports diagnosis and treatment of ear, nose and throat conditions in both routine care and more complex procedures. - Rising hearing loss worldwide is expanding demand for portable tools that can assess auditory function and support timely treatment. - Growth in this market also points to broader shifts toward outpatient care, ambulatory surgical centers and minimally invasive ENT procedures.

What happened: - The Business Research Company said the ENT handheld instruments market is expected to rise from $8.59 billion in 2025 to $9.36 billion in 2026. - The company projects the market will reach $13.08 billion by 2030. - The forecast implies compound annual growth of 8.9% from 2025 to 2026 and 8.7% through 2030. - North America held the largest share of the market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - ENT handheld instruments are specialized medical devices used to evaluate, diagnose and treat diseases affecting the ear, nose and throat. - The market’s recent growth has been driven by advances in medical technology and rising healthcare demand. - Historical growth factors include increasing prevalence of ENT disorders, more specialty clinics, more outpatient ENT procedures, a higher rate of endoscopic examinations and standardized surgical equipment availability. - Future growth factors include earlier diagnosis of ENT conditions, more demand for portable diagnostic devices, expansion of ambulatory surgical centers, stronger patient-safety focus and ongoing innovation in handheld medical instruments. - Emerging trends include ergonomic instrument designs, more minimally invasive ENT tools, advanced diagnostic handheld devices, more disposable and single-use instruments and tighter infection-control protocols. - The company also said its 2026 reports include market-attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market-hotspot infographics, key-technology analysis, future-trend analysis and updated graphics and tables. - The report includes a free sample and the full market report is available online: Download a free sample and View the full report.

Between the lines: - The hearing-loss backdrop is a major demand signal for ENT handheld instruments because the devices help clinicians evaluate and manage patients quickly. - WHO said in February 2024 that about 430 million people, including 34 million children, needed rehabilitation for disabling hearing loss. - WHO also projected that by 2050 nearly 2.5 billion people will have some degree of hearing loss, with at least 700 million needing hearing rehabilitation. - The market’s shift toward disposable instruments and infection-control measures reflects higher sensitivity to safety in clinical settings.

What's next: - The market is expected to keep expanding through 2030 as demand grows for early diagnosis, portable devices and outpatient ENT care. - Product development is likely to keep moving toward ergonomic, minimally invasive and digitally enabled handheld instruments. - Stronger adoption of single-use tools and infection-control practices may continue to reshape purchasing decisions.

The bottom line: - ENT handheld instruments are moving from a routine clinical category to a growth market tied to hearing-loss treatment, outpatient care and technology upgrades.